Studies in experimental autoimmune encephalomyelitis (EAE) mice, the most common model of MS, also have exhibited the therapeutic potential of exosome by secretion of immunomodulatory factors, down-regulation of NALP3 inflammasome activation, and also deterring of NF-κB expression levels in vivo [189]. The gene discussed is NLRP3; the disease is myeloid sarcoma.